NT

Nitin Tomar

Active Director Director DIN 09420531
DIN 09420531 First appointment Dec 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value •••• Premium profile

About Nitin Tomar

Data last updated:

Nitin Tomar is a Director at Ameo Pharma Private Limited (since 2021). The company operates in Chemicals. Ameo Pharma Private Limited reported revenue of ₹18.4 Lakh (FY 2023).

DIN 09420531
Primary Designation Director
Industry Chemicals
First Appointment 01 Dec 2021
Oldest Company Age 6 yrs
Largest company Ameo Pharma Private Limited · ₹18.4 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ameo Pharma Private Limited U24110DL2020PTC362452
Director01 Dec 20212020₹18.4 Lakh (FY 2023)Active

Board colleagues of Nitin Tomar

NameDINCompanyDesignation
Rinky Tomar08713398Ameo Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ameo Pharma Private Limited
Premium access

Shareholding and investment profile for Nitin Tomar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nitin Tomar

Nitin Tomar currently holds 1 directorship: Ameo Pharma Private Limited (Director, since 01 Dec 2021, revenue ₹18.4 Lakh (FY 2023)).

Nitin Tomar was first appointed on 01 Dec 2021 as Director at Ameo Pharma Private Limited.

The current boards of Nitin Tomar's companies include Rinky Tomar (Ameo Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available